JP Morgan Reinstates Overweight on PACS Group, Announces $44 Price Target

Benzinga · 12/17/2025 13:48
JP Morgan analyst Benjamin Rossi reinstates PACS Group (NYSE:PACS) with a Overweight and announces $44 price target.